Biogen HQ Sale One of Biggest of Year

The Kendall Square HQ building of Biogen (225 Binney St, Cambridge) is about to be sold. TIAA-CREF announced Tuesday that its real estate arm will purchase a 70% stake in the building from Alexandria Real Estate Equities. The transaction is worth $190.1M and values the 305k SF building at $271.6M. At $889 PSF, the deal comes in at a higher price than any other deal in the area this year, the Boston Globe reports. Biogen has a long-term lease for the six-story building built by Alexandria. The deal is expected to close in Q4. [Globe]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Women In Bay Area CRE Still Face Challenges But Lean Into Authenticity As Their Edge

Lender Takes Control Of Vacant Somerville Lab Building Following Failed Sale

Kraft Group Seeks To Build $16B Data Center Campus: The Boston Deal Sheet

West Palm Beach Commissioners OK Related Ross' Plans For Air Taxi Stop

Wu Proposes Loosening Affordable Housing Mandates To Spur Development

Democrats' Sweep In Pennsylvania Expected To Boost Multifamily, Hinder Data Centers

Washington Never Delivered Crypto Rules. That's Not What's Stalling Tokenized Real Estate

Why Durham? Ternstone Holdings Explains Its Development Strategy

'Certainty Will Be The Buzzword': Stability, Not Sea Change, For CRE Post-Midterm

Former Vornado Exec Gets 11 Years In Prison For Stealing $9.5M From REIT

LA's New Mayor Is Nithya Raman, Housing Developers' Friend And Foe

Revere Housing Authority Seeks Zoning Change For 1,700-Unit Redevelopment